Interim study findings indicate that a new antiretroviral combination pill taken once weekly is as effective as current daily treatment regimens for HIV. These results are scheduled to be presented at the upcoming AIDS 2026 conference in Rio de Janeiro, Brazil.
The development represents a potential shift in HIV management, as researchers look to simplify treatment protocols. If confirmed, a once-weekly medication could offer an alternative to the standard daily pill regimen, potentially improving adherence and quality of life for patients managing the virus.
In-depth summary · AI, neutral